Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Duke University
Thomas Jefferson University
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Royal Marsden NHS Foundation Trust
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
The Netherlands Cancer Institute
National Institutes of Health Clinical Center (CC)
Stanford University
Murdoch Childrens Research Institute
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Medical Research Center for Therapy and Preventive Medicine
National Institutes of Health Clinical Center (CC)
Samara State Medical University
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
I.M. Sechenov First Moscow State Medical University
University Medical Center Groningen
National Institutes of Health Clinical Center (CC)
Istanbul University
Istanbul University
RenJi Hospital
M.D. Anderson Cancer Center
Western Galilee Hospital-Nahariya